ADVANCED MALIGNANT TUMOR
Clinical trials for ADVANCED MALIGNANT TUMOR explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT TUMOR trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double antibody attack: early trial combines immune and Growth-Signal blockers against advanced cancers
Disease control CompletedThis early-stage trial is testing a combination of two lab-made antibodies in people with advanced solid tumors that have not responded to standard treatments. One antibody (LDP) aims to reactivate the immune system against cancer, while the other (CDP1) blocks a growth signal on…
Matched conditions: ADVANCED MALIGNANT TUMOR
Phase: PHASE1 • Sponsor: Dragonboat Biopharmaceutical Company Limited • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New antibody aims to unleash immune system against advanced tumors
Disease control CompletedThis early-stage trial tests a new drug called LDP, an antibody that blocks PD-L1, a protein cancers use to hide from the immune system. The study enrolls adults with advanced malignant tumors who have exhausted standard treatments. Researchers are evaluating the drug's safety, t…
Matched conditions: ADVANCED MALIGNANT TUMOR
Phase: PHASE1 • Sponsor: Dragonboat Biopharmaceutical Company Limited • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New pill HRS7415 shows promise in early cancer trial
Disease control CompletedThis early-phase study tested a new drug called HRS7415 in 38 people with advanced cancers that had spread. The main goals were to check safety, find the right dose, and see if the drug could help control the disease. Researchers monitored side effects and measured drug levels in…
Matched conditions: ADVANCED MALIGNANT TUMOR
Phase: PHASE1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New Dual-Action antibody takes on advanced tumors
Disease control CompletedThis early-stage trial tested a new drug called BAT7104 in 86 people with advanced cancers that had stopped responding to standard treatments. The drug is a bispecific antibody designed to block two proteins (PD-L1 and CD47) that help tumors hide from the immune system. The main …
Matched conditions: ADVANCED MALIGNANT TUMOR
Phase: PHASE1 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC